Brentuximab Vedotin and Lenalidomide in Patients With Relapsed/ Refractory T-cell Lymphoma or Hodgkin Lymphoma
Condition(s):Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Hodgkin LymphomaLast Updated:May 19, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell, Peripheral; Hodgkin LymphomaLast Updated:May 19, 2022Completed
Condition(s):LymphomaLast Updated:September 18, 2023Active, not recruiting
Condition(s):T-Cell LymphomaLast Updated:September 18, 2023Active, not recruiting
Condition(s):Hodgkin Disease; Lymphoma, Large-Cell, AnaplasticLast Updated:February 24, 2021Completed
Condition(s):Hodgkin LymphomaLast Updated:April 9, 2021Completed
Condition(s):Peripheral T Cell Lymphoma; Pediatric Hodgkin LymphomaLast Updated:January 16, 2024Completed
Condition(s):Acute Lymphoid Leukemia; Acute Myeloid Leukemia; Anemia, Refractory, With Excess of Blasts; Solid TumorsLast Updated:March 4, 2016Completed
Condition(s):CD-30 Positive Anaplastic Large T-cell Cutaneous Lymphoma; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Lymphomatoid Papulosis; Mycosis Fungoides; Skin Lymphoma; Cutaneous Lymphomas; Lymphoma; Hematologic DisorderLast Updated:December 13, 2023Active, not recruiting
Condition(s):Primary Mediastinal Large B Cell LymphomaLast Updated:June 26, 2017Completed
Condition(s):Recurrent Hodgkin Lymphoma; Refractory Hodgkin LymphomaLast Updated:February 16, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.